GT BIOPHARMA, INC. Total Liabilities
GT BIOPHARMA, INC. (GTBP) had Total Liabilities of $1.32 million as of 2025-09-30, per its 10-Q/A filed 2026-03-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-03-06
- 2025-09-30: Liabilities $1.32M.
- 2025-06-30: Liabilities $31.04M.
- 2024-03-31: Liabilities $4.60M.
- 2023-12-31: Liabilities $6.63M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2025-09-30 | $1.32M 10-Q/A · filed 2026-03-06 | |
| 2025-06-30 | $31.04M 10-Q/A · filed 2026-03-06 | |
| 2024-03-31 | $4.60M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $6.63M 10-Q · filed 2024-05-15 | |
| 2023-09-30 | $6.14M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $6.38M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $7.03M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $5.00M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $5.12M 10-Q · filed 2022-10-31 | |
| 2022-06-30 | $8.73M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $9.65M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $10.26M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $30.69M 10-Q · filed 2020-11-13 | |
| 2020-03-31 | $21.15M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $19.71M 10-Q · filed 2020-11-13 | |
| 2019-09-30 | $18.77M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $16.73M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $15.52M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $14.03M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $13.22M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $8.95M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $5.08M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $2.68M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $2.80M 10-Q · filed 2017-11-14 | |
| 2017-03-31 | $18.35M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $18.95M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $17.37M 10-Q/A · filed 2018-02-28 | |
| 2016-06-30 | $16.19M 10-Q/A · filed 2018-02-28 | |
| 2016-03-31 | $20.26M 10-Q/A · filed 2018-02-28 | |
| 2015-12-31 | $50.62M 10-K/A · filed 2018-02-28 | $61.89M 10-K · filed 2016-03-30 |
| 2015-09-30 | $24.60M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $23.03M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $51.36M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $30.46M 10-K/A · filed 2018-02-28 | |
| 2014-09-30 | $11.61M 10-Q · filed 2015-01-08 | |
| 2014-06-30 | $7.02M 10-Q · filed 2015-01-08 | |
| 2014-03-31 | $6.81M 10-Q · filed 2015-01-08 | |
| 2013-12-31 | $6.48M 10-K · filed 2015-03-31 | |
| 2012-12-31 | $6.56M 10-K · filed 2015-01-08 | |
| 2011-12-31 | $5.23M 10-K · filed 2012-04-16 | |
| 2010-12-31 | $5.65M 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |